Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites

被引:146
作者
Hong, J
Lambert, JD
Lee, SH
Sinko, PJ
Yang, CS [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
关键词
EGCG; efflux; Pgp; MRP; MDCKII cell;
D O I
10.1016/j.bbrc.2003.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(-)-Epigallocatechin-3-gallate (EGCG), a major polyphenol of green tea, has many interesting biological activities. The uptake of EGCG and involvement of specific efflux pumps were studied in MDCKII cells transfected with hPgp, hMRP1, and hMRP2 genes. Total cell associated [H-3]EGCG increased 7-fold in the presence of the MRP inhibitors, indomethacin and probenecid, in MDCKII/MRP1 cells, compared to a 2-fold increase in wild-type cells. Intracellular levels of EGCG, 4"-O-methyl EGCG, and 4',4"-di-O-methyl EGCG were increased by 13-, 11-, and 3-fold, respectively, by indomethacin in MDCKII/MRP1 cells. Accumulation of EGCG and its methyl metabolites was also increased similar to10-fold in the presence of MK-571 in MDCKII/MRP2 cells. Co-treatment with isoflavones, curcumin and tetrahydrocurcumin, increased [H-3]EGCG accumulation significantly in MDCKII/MRP1 and HT-29 cells. The results indicate that EGCG and its methyl metabolites are substrates for MRP1 and MRP2, but not for Pgp. MRP type efflux pumps may limit the bioavailability of EGCG. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:222 / 227
页数:6
相关论文
共 27 条
[1]   Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells [J].
Anuchapreeda, S ;
Leechanachai, P ;
Smith, MM ;
Ambudkar, SV ;
Limtrakul, P .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (04) :573-582
[2]   Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells [J].
Berger, SJ ;
Gupta, S ;
Belfi, CA ;
Gosky, DM ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (01) :101-105
[3]   Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats [J].
Cai, Y ;
Anavy, ND ;
Chow, HHS .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) :1246-1249
[4]   Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats [J].
Chen, C ;
Hennig, GE ;
Manautou, JE .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) :798-804
[5]  
Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
[6]  
Hong J, 2002, CANCER RES, V62, P7241
[7]   Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols [J].
Jodoin, J ;
Demeule, M ;
Béliveau, R .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1542 (1-3) :149-159
[8]   Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration [J].
Kohri, T ;
Nanjo, F ;
Suziki, M ;
Seto, R ;
Matsumoto, N ;
Yamakawa, M ;
Hojo, H ;
Hara, Y ;
Desai, D ;
Amin, S ;
Conaway, CC ;
Chung, FL .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (02) :1042-1048
[9]  
Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
[10]   Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters [J].
Leslie, EM ;
Deeley, RG ;
Cole, SPC .
TOXICOLOGY, 2001, 167 (01) :3-23